| Shasun Pharmaceuticals has reported a consolidated total income from operations of Rs 339.28 crore and a net profit of Rs 13.09 crore for the quarter ended Sep '15. | | For the quarter ended Sep 2014 the consolidated total income from operations was Rs 319.96 crore and net profit was Rs 0.25 crore. | | Shasun Pharma shares closed at 397.15 on October 27, 2015 (NSE) and has given 35.69% returns over the last 6 months and 98.43% over the last 12 months. |
|
| | Shasun Pharmaceuticals | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Sep '15 | Jun '15 | | | Sep '14 | | Net Sales/Income from operations | 323.32 | 319.17 | | | 306.03 | | Other Operating Income | 15.96 | 14.40 | | | 13.93 | | Total Income From Operations | 339.28 | 333.57 | | | 319.96 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 170.52 | 172.07 | | | 162.59 | | Purchase of Traded Goods | 1.45 | 0.62 | | | 2.68 | | Increase/Decrease in Stocks | -12.30 | -0.94 | | | 3.96 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 65.57 | 56.78 | | | 60.79 | | Depreciation | 15.29 | 14.46 | | | 9.98 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 76.55 | 74.32 | | | 70.54 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 22.20 | 16.26 | | | 9.42 | | Other Income | 4.08 | 1.09 | | | 4.26 | | P/L Before Int., Excpt. Items & Tax | 26.28 | 17.35 | | | 13.68 | | Interest | 11.55 | 12.36 | | | 12.36 | | P/L Before Exceptional Items & Tax | 14.73 | 4.99 | | | 1.32 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | 14.73 | 4.99 | | | 1.32 | | Tax | 1.63 | 1.18 | | | 0.02 | | P/L After Tax from Ordinary Activities | 13.10 | 3.81 | | | 1.30 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | 13.10 | 3.81 | | | 1.30 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -0.01 | -0.01 | | | -1.05 | | Net P/L After M.I & Associates | 13.09 | 3.80 | | | 0.25 | | Equity Share Capital | 13.45 | 13.45 | | | 12.03 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | 1.95 | 0.61 | | | 0.04 | | Diluted EPS | 1.95 | 0.60 | | | 0.04 | | EPS After Extra Ordinary | | | | | | | Basic EPS | 1.95 | 0.61 | | | 0.04 | | Diluted EPS | 1.95 | 0.60 | | | 0.04 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 4.35 | 4.35 | | | 3.64 | | Share Holding (%) | 64.68 | 64.68 | | | 60.51 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 0.41 | 0.44 | | | 0.41 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 17.32 | 18.41 | | | 17.28 | | - Per. of shares (as a % of the total Share Cap. of the company) | 6.12 | 6.50 | | | 6.82 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 1.96 | 1.94 | | | 1.96 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 82.68 | 81.59 | | | 82.72 | | - Per. of shares (as a % of the total Share Cap. of the company) | 29.20 | 28.82 | | | 32.67 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
